Search

23 Feb 2024: STEM-PD uses human embryonic stem cells, a type of cell that can turn into almost any type of […]. Filed Under:12th October 2022. In research published today in Alzheimer’s & ... Filed Under:13th May 2022. The research, from the University of

23 Feb 2024: England Research Consortium.

23 Feb 2024: Filed Under:10th August 2021. Dr Timothy Rittman is the clinical lead of the QMIN-MC trial, which uses a machine learning algorithm developed by Prof Zoe Kourtzi, research lead at ... The new Fellows have been selected for their exceptional contributions

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Jelle van den Ameele. Jelle van den Ameele. ... In 2020, Jelle became a Wellcome Clinical Research Career Development Fellow at the Department of Clinical Neurosciences and MRC Mitochondrial Biology Unit

23 Feb 2024: Jess’ research has led to the launch of a clinical trial, which is testing a new treatment to slow down the […]. Filed Under:5th June 2019. Results indicate that early treatment ... MRC Clinical Director He joins the senior management team and will

23 Feb 2024: SOUND Laboratory. Marina Salorio-Corbetto. Marina is a Research Associate who has previously worked as a clinical audiologist. ... While at the Auditory Perception Group, Marina started collaborating with Dr Josephine Marriage as a Research Audiologist.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial Starts. 22nd March 2022. ... purpose of this research is therefore to assess whether metformin and clemastine.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Publications. Six months of bexarotene reduces the VEP latency, implying remyelination (Brown Lancet Neurol 2021). ... PMID: 36116011; PMCID: PMC9539389. Needham EJ, …. Coles AJ, Menon DK; Cambridge

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Psychosis Clinical Trial. SINAPPS-2 trial. SINAPPS2 is a phase II ongoing clinical trial aiming to test the efficacy and safety of immunotherapy (intravenous immunoglobulin combined

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... This new research is a major milestone in our plan to stop MS and we’re incredibly excited about the potential it’s shown for future studies.